NCT05908786 2025-12-11A Study Evaluating The Efficacy and Safety of Neoadjuvant Immunotherapy Combinations in Patients With Surgically Resectable Hepatocellular CarcinomaHoffmann-La RochePhase 1/2 Completed62 enrolled